# A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe

> **NCT02848521** · — · UNKNOWN · sponsor: **Otsuka Pharmaceutical Europe Ltd** · enrollment: 407 (actual)

## Conditions studied

- Autosomal Dominant Polycystic Kidney Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02848521
- **Lead sponsor:** Otsuka Pharmaceutical Europe Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-10
- **Final completion:** 2020-03
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2019-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848521, "A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02848521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*